Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 296 | $225,190,504 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Feb 2023 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 14 Feb 2023 | Sale | 279 | 301.11 | 84,010 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 283 | 299.79 | 84,841 | D |
09 Nov 2022 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 07 Nov 2022 | Sale | 280 | 304.58 | 85,282 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 292 | 295.89 | 86,400 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 300 | 288.74 | 86,622 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 292 | 297.54 | 86,882 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 288 | 301.84 | 86,930 | D |
11 Oct 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 06 Oct 2023 | Sale | 242 | 360 | 87,120 | D |
28 Feb 2023 16:40 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 27 Feb 2023 | Sale | 302 | 289.6 | 87,459 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 300 | 292.86 | 87,858 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 302 | 293.99 | 88,785 | D |
19 Oct 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 17 Oct 2023 | Sale | 243 | 375 | 91,125 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 300 | 305.57 | 91,671 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 308 | 301.02 | 92,714 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 327 | 288.91 | 94,474 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 302 | 315.42 | 95,257 | D |
01 Jun 2023 16:12 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 30 May 2023 | Sale | 289 | 329.82 | 95,318 | D |
03 Apr 2024 16:02 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 02 Apr 2024 | Sale | 240 | 419 | 100,560 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 361 | 286.64 | 103,477 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 324 | 321.84 | 104,276 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 02 May 2023 | Sale | 300 | 353.18 | 105,954 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 360 | 294.52 | 106,027 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 349 | 305.08 | 106,473 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 360 | 298.09 | 107,312 | D |
28 Feb 2023 16:47 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 27 Feb 2023 | Sale | 400 | 287.59 | 115,036 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 394 | 295.38 | 116,380 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 395 | 297.97 | 117,698 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 400 | 300.89 | 120,356 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 400 | 302.55 | 121,020 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 379 | 321.31 | 121,776 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 420 | 292.41 | 122,812 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 08 Aug 2022 | Sale | 424 | 291.53 | 123,609 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 400 | 320.25 | 128,100 | D |
13 Feb 2024 17:23 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 12 Feb 2024 | Sale | 314 | 420.24 | 131,955 | D |
19 Jan 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 18 Jan 2023 | Sale | 442 | 312.17 | 137,979 | D |
09 May 2023 16:15 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 05 May 2023 | Sale | 422 | 350.03 | 147,713 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 515 | 287.83 | 148,232 | D |
14 Feb 2023 16:49 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 13 Feb 2023 | Sale | 500 | 300.23 | 150,115 | D |
27 Feb 2024 17:02 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 26 Feb 2024 | Sale | 354 | 425.7 | 150,698 | D |
23 Feb 2024 16:28 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 21 Feb 2024 | Sale | 360 | 421.77 | 151,837 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 478 | 319.25 | 152,602 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 10 Mar 2023 | Sale | 541 | 291.47 | 157,685 | D |
22 Feb 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2023 | Sale | 545 | 292.77 | 159,560 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 560 | 298.14 | 166,958 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 579 | 314.95 | 182,356 | D |
03 May 2024 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 02 May 2024 | Sale | 467 | 402.95 | 188,178 | D |
08 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 06 Feb 2023 | Sale | 620 | 306.7 | 190,154 | D |
26 Oct 2022 16:05 | VRTX | VERTEX PHARMACEUTICALS INC | BHATIA SANGEETA N. | Director | 24 Oct 2022 | Sale | 621 | 310 | 192,510 | D |
21 Feb 2024 16:43 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 20 Feb 2024 | Sale | 480 | 420.79 | 201,979 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 09 Aug 2022 | Sale | 679 | 298.77 | 202,865 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 698 | 301.63 | 210,538 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 715 | 294.52 | 210,582 | D |
03 Oct 2023 16:07 | VRTX | VERTEX PHARMACEUTICALS INC | BILLER JONATHAN | EVP and Chief Legal Officer | 02 Oct 2023 | Sale | 610 | 346.76 | 211,524 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 700 | 303.99 | 212,793 | D |
22 Feb 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2023 | Sale | 736 | 294.58 | 216,811 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 680 | 320.94 | 218,239 | D |
28 Feb 2023 16:47 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 27 Feb 2023 | Sale | 800 | 288.92 | 231,136 | D |
21 Mar 2023 16:21 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 17 Mar 2023 | Sale | 784 | 295.43 | 231,617 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 800 | 295.79 | 236,632 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 800 | 295.84 | 236,672 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 03 May 2023 | Sale | 700 | 351.59 | 246,113 | D |
09 May 2023 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 05 May 2023 | Sale | 708 | 349.38 | 247,361 | D |
16 Feb 2023 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 14 Feb 2023 | Sale | 842 | 296.85 | 249,948 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 25 Jan 2023 | Sale | 800 | 312.8 | 250,240 | D |
14 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Feb 2023 | Sale | 835 | 300.13 | 250,609 | D |
04 May 2023 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 03 May 2023 | Sale | 728 | 351.6 | 255,965 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 900 | 294.73 | 265,257 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 901 | 296.85 | 267,462 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 09 Aug 2022 | Sale | 900 | 301.42 | 271,278 | D |
14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 12 Feb 2024 | Sale | 647 | 420.39 | 271,992 | D |
21 Jul 2022 16:48 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 19 Jul 2022 | Sale | 963 | 286.72 | 276,111 | D |
28 Feb 2023 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 27 Feb 2023 | Sale | 982 | 287.25 | 282,080 | D |
10 Aug 2022 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 09 Aug 2022 | Sale | 946 | 300 | 283,800 | D |
14 Apr 2023 16:19 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 12 Apr 2023 | Sale | 874 | 325.7 | 284,662 | D |
14 Feb 2024 16:04 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 13 Feb 2024 | Sale | 737 | 419.13 | 308,899 | D |
31 Jan 2023 16:42 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 27 Jan 2023 | Sale | 970 | 322.2 | 312,534 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 1,000 | 317.95 | 317,950 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 1,000 | 320.7 | 320,700 | D |
22 Feb 2023 16:30 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 21 Feb 2023 | Sale | 1,100 | 293.74 | 323,114 | D |
21 Feb 2024 16:23 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 20 Feb 2024 | Sale | 801 | 420.79 | 337,053 | D |
14 Mar 2023 16:22 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 13 Mar 2023 | Sale | 1,153 | 293.35 | 338,233 | D |
22 Feb 2023 16:25 | VRTX | VERTEX PHARMACEUTICALS INC | ALTSHULER DAVID | EVP, Global Research and CSO | 21 Feb 2023 | Sale | 1,223 | 292.76 | 358,045 | D |
27 Jan 2023 16:18 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 26 Jan 2023 | Sale | 1,140 | 316.82 | 361,175 | D |
27 Feb 2024 16:44 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 26 Feb 2024 | Sale | 883 | 425.7 | 375,893 | D |
27 Feb 2024 16:29 | VRTX | VERTEX PHARMACEUTICALS INC | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 26 Feb 2024 | Sale | 883 | 425.7 | 375,893 | D |
17 Aug 2022 17:39 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 15 Aug 2022 | Sale | 1,254 | 300.3 | 376,576 | D |
13 Feb 2024 16:54 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 12 Feb 2024 | Sale | 913 | 420.24 | 383,679 | D |
02 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | SACHS BRUCE I | Director | 31 Jan 2023 | Sale | 1,200 | 325.01 | 390,012 | D |
09 May 2023 16:10 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 08 May 2023 | Sale | 1,125 | 349 | 392,625 | D |
24 Feb 2023 16:06 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 22 Feb 2023 | Sale | 1,378 | 294.29 | 405,532 | D |
31 Jan 2023 16:45 | VRTX | VERTEX PHARMACEUTICALS INC | CARNEY LLOYD | Director | 30 Jan 2023 | Sale | 1,376 | 320.08 | 440,430 | D |
20 Oct 2022 16:11 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 18 Oct 2022 | Sale | 1,503 | 300.02 | 450,930 | D |
25 Jan 2023 16:08 | VRTX | VERTEX PHARMACEUTICALS INC | LEE YUCHUN | Director | 24 Jan 2023 | Sale | 1,489 | 313.36 | 466,593 | D |
04 May 2023 16:51 | VRTX | VERTEX PHARMACEUTICALS INC | SANNA BASTIANO | EVP, Cell & Genetic Therapies | 02 May 2023 | Sale | 1,411 | 350.32 | 494,302 | D |
23 Feb 2024 16:16 | VRTX | VERTEX PHARMACEUTICALS INC | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 21 Feb 2024 | Sale | 1,201 | 421.77 | 506,546 | D |
16 Feb 2023 16:14 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 14 Feb 2023 | Sale | 1,734 | 300.09 | 520,356 | D |
04 May 2023 16:50 | VRTX | VERTEX PHARMACEUTICALS INC | LEIDEN JEFFREY M | Executive Chairman | 02 May 2023 | Sale | 1,505 | 350.48 | 527,472 | D |
17 Aug 2022 17:36 | VRTX | VERTEX PHARMACEUTICALS INC | LIU JOY | SVP, General Counsel | 15 Aug 2022 | Sale | 1,743 | 305.01 | 531,632 | D |
14 Feb 2023 16:53 | VRTX | VERTEX PHARMACEUTICALS INC | ARBUCKLE STUART A | EVP, COO | 13 Feb 2023 | Sale | 1,779 | 299.26 | 532,384 | D |
28 Mar 2023 16:13 | VRTX | VERTEX PHARMACEUTICALS INC | WAGNER CHARLES F JR | EVP & Chief Financial Officer | 24 Mar 2023 | Sale | 1,768 | 305.38 | 539,912 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)